These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20549884)

  • 1. Special issue on diabetes. Introduction.
    Brunton SA
    J Fam Pract; 2010 May; 59(5 Suppl):S2. PubMed ID: 20549884
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing diabetic dyslipidemia: aggressive approach.
    Spratt KA
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):S2-7. PubMed ID: 19451254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating dyslipidaemia in the setting of diabetes mellitus and cardiovascular disease: another focus.
    Tahrani AA
    Int J Clin Pract; 2006 Nov; 60(11):1515; author reply 1515-6. PubMed ID: 17073848
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].
    Båvenholm P; Attvall S; Nilsson PM
    Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2462-6. PubMed ID: 17002161
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

  • 6. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid.
    Cardiovasc J Afr; 2008; 19(3):171-2. PubMed ID: 18568186
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic syndrome: diabetes and cardiovascular disease.
    Gupta S; Gupta BM
    Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of statins in managing diabetic dyslipidemia.
    Toth PP
    J Fam Pract; 2010 May; 59(5 Suppl):S23-9. PubMed ID: 20544054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Principle of the therapy of non-insulin dependent diabetes mellitus].
    Nakagawa S
    Nihon Rinsho; 1990 Dec; 48 Suppl():810-5. PubMed ID: 2086960
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients.
    Pinheiro JS; Schiavon CA; Pereira PB; Correa JL; Noujaim P; Cohen R
    Surg Obes Relat Dis; 2008; 4(4):521-5; discussion 526-7. PubMed ID: 18539540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of simvastatin in elderly patients with type 2 diabetes].
    Gonokhova LG
    Kardiologiia; 2006; 46(8):29-32. PubMed ID: 17058344
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes mellitus, hypertension and obesity--common multifactorial disorders in Saudis.
    Warsy AS; el-Hazmi MA
    East Mediterr Health J; 1999 Nov; 5(6):1236-42. PubMed ID: 11924118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solvay addresses unmet needs in the management of hypertensive patients with cardiometabolic and lipid disorders.
    Cardiovasc J Afr; 2009; 20(1):73-4. PubMed ID: 19287821
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of dyslipidemias in patients with diabetes and chronic kidney disease.
    Molitch ME
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1090-9. PubMed ID: 17699330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic effects of 11beta-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis.
    Lloyd DJ; Helmering J; Cordover D; Bowsman M; Chen M; Hale C; Fordstrom P; Zhou M; Wang M; Kaufman SA; Véniant MM
    Diabetes Obes Metab; 2009 Jul; 11(7):688-99. PubMed ID: 19527482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to reduce complications of type 2 diabetes.
    Ullom-Minnich P
    J Fam Pract; 2004 May; 53(5):366-75. PubMed ID: 15125821
    [No Abstract]   [Full Text] [Related]  

  • 17. Controversies in dyslipidemias: atheroprevention in diabetes and insulin resistance.
    Brinton EA
    Ann N Y Acad Sci; 2005 Dec; 1055():159-78. PubMed ID: 16387723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Type 2 diabetes. Restoring two treatments of the ACCORD study].
    Sabourin G
    Perspect Infirm; 2010; 7(6):33-4. PubMed ID: 21141631
    [No Abstract]   [Full Text] [Related]  

  • 20. Surprises and reaffirmations in 2008 clinical trials.
    Mandell BF
    Cleve Clin J Med; 2009 Jan; 76(1):6. PubMed ID: 19122106
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.